Study of Ruxolitinib Cream in Adolescents With Atopic Dermatitis

NCT05456529 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis (AD)

Interventions

DRUG: Ruxolitinib Cream

Sponsor

Incyte Corporation